Type 2 Diabetes Mellitus: Exploring Immunogenetic Pathways. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Elsevier, 2026
- Erstausgabe
- Softcover
- Neu

Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandKennys Bookshop and Art Galleries Ltd.
Verkäufer:in bei ZVAB seit 27. Februar 2001
Zustand: Neu
EUR 401,19
Artikelbeschreibung des Verkäufers
2026. 1st Edition. paperback. . . . . .
Bestandsnummer des Verkäufers V9780443335907
- Titel
- Type 2 Diabetes Mellitus: Exploring Immunogenetic Pathways
- Verlag
- Elsevier
- Erscheinungsjahr
- 2026
- Zustand
- New
- Einband
- Softcover
- Sprache
- Englisch
- ISBN-10
- 0443335907
- ISBN-13
- 9780443335907
- Auflage
- 1. Auflage
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Shafat Ali (Ph.D.) pursued his BSc. from University of Kashmir and Masters in Zoology from Barkatullah Vishwavidyalaya, India. Currently he is engaged in research work for last 5 years at Cytogenetics and Molecular Biology Laboratory, Centre of Research for Development, University of Kashmir, Department of Biochemistry, Government Medical College, Srinagar, Jammu and Kashmir, and ICMR funded Multidisciplinary Research Unit, Government Medical College, Srinagar, Jammu and Kashmir, India, with specialization in the field of reproductive immunogenetics, cytokine biology, gynaecology and obstetrics, molecular biology, cancer biology and cytogenetics. He has 5 years of research experience and 5 years of teaching experience. He has more than 20 book chapters, several edited books and numerous peer-reviewed, international research publications to his credit. Dr. Ali is also the reviewer of many reputed international journals. Presently, Dr. Ali is involved in studying immunogenetic mechanisms involved in recurrent pregnancy loss.
Dr. Yahya F. Jamous is a Saudi pharmaceutical scientist and Associate Research Professor at Institute of Health Technologies and Preventative Medicine, Health Sector, King Abdulaziz City of Science and Technology (KACST), Riyadh. He has been in the research and teaching field of over 15 years has an excellent history of scientific publications in pharmaceutical biotechnology, nanotechnology, and molecular pharmacology.
Dr. Jamous has served KACST in various high-ranking academic and administrative roles, such as Associate Research Professor, Assistant Research Professor, Acting Director of National Partnerships, and a former Director of the National Vaccines and Bioprocessing Centre (NVBC) in support of programs that go in line with Saudi Vision 2030.
He has a PhD in Molecular Pharmacology at ETH Zurich in new therapeutic targets in heart failure and MSc and BSc degrees in Pharmaceutical Sciences at King Saud University. Dr. Jamous is a licensed Consultant of Pharmaceutical Sciences.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.